McCann Corey's Form 4 filing
Pear Therapeutics, Inc. (PEAR) · filed Jan 24, 2023
- Accession no.
- 0001062993-23-001323
- Filed
- Jan 24, 2023
- Trade date
- Jan 20, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $39.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McCann CoreyCIK 0001881049 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 | Class A Common Stock | SSaleDisposed | −34,731 | $1.13 | −$39,246.03 | 8,210,834 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.